Akums Drugs and Pharmaceuticals Limited — Important, 08-08-2025: Updates

Akums Drugs incurred fines from stock exchanges for a past non-compliance concerning the composition of its Board of Directors. The company clarified the delay in appointing an independent director was unintentional. Importantly, Akums has since rectified this issue by successfully appointing the required director to its Board. Furthermore, the company has applied for a waiver of the imposed fines, and a decision from the exchanges is currently pending. This demonstrates the company's proactive steps in addressing the governance concern.